Cohen Neil Harris
Insider CIK 1840006 · CMMB interim CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CMMB Chemomab Therapeutics Ltd. | S Sale | 2026-08-28 | 2026-09-01 | 1,000 | $2.80 | $2.8K | 33,000 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | S Sale | 2026-08-28 | 2026-09-01 | 1,000 | $2.80 | $2.8K | 33,000 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | S Sale | 2026-08-27 | 2026-09-01 | 1,304 | $2.85 | $3.7K | 34,000 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | S Sale | 2026-08-27 | 2026-09-01 | 1,304 | $2.85 | $3.7K | 34,000 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2026-03-16 | 2026-09-01 | 5,172 | — | $0 | 18,075 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2026-03-16 | 2026-09-01 | 5,172 | — | $0 | 18,075 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2025-03-16 | 2026-09-01 | 3,821 | — | $0 | 12,903 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2025-03-16 | 2026-09-01 | 3,821 | — | $0 | 12,903 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2024-03-18 | 2026-09-01 | 2,520 | — | $0 | 9,082 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2024-03-18 | 2026-09-01 | 2,520 | — | $0 | 9,082 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2023-03-21 | 2026-09-01 | 1,714 | — | $0 | 6,562 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2023-03-21 | 2026-09-01 | 1,714 | — | $0 | 6,562 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2023-03-16 | 2023-03-23 | 6,875 | — | $0 | 6,875 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | S Sale | 2022-11-16 | 2022-11-18 | 2,409 | $2.00 | $4.8K | 10,000 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | P Buy | 2022-05-18 | 2022-05-19 | 2,000 | $3.19 | $6.4K | 12,409 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | P Buy | 2022-03-14 | 2022-03-15 | 2,000 | $4.20 | $8.4K | 6,409 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | P Buy | 2022-03-14 | 2022-03-15 | 2,000 | $4.30 | $8.6K | 8,409 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | P Buy | 2022-03-14 | 2022-03-15 | 2,000 | $4.56 | $9.1K | 10,409 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2022-03-07 | 2026-09-01 | 1,705 | — | $0 | 4,848 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2022-03-07 | 2023-03-23 | 6,820 | — | $0 | 6,820 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2022-03-07 | 2022-11-18 | 6,820 | — | $0 | 6,820 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2022-03-07 | 2022-05-19 | 6,820 | — | $0 | 6,820 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2022-03-07 | 2022-03-09 | 6,820 | — | $0 | 6,820 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2022-03-07 | 2022-03-15 | 6,820 | — | $0 | 6,820 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2022-03-07 | 2026-09-01 | 1,705 | — | $0 | 4,848 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | P Buy | 2021-12-06 | 2021-12-08 | 2,000 | $7.43 | $14.9K | 4,409 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-04-19 | 2026-09-01 | 2,971 | — | $0 | 3,143 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-04-19 | 2023-03-23 | 11,884 | — | $0 | 11,884 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-04-19 | 2022-11-18 | 11,884 | — | $0 | 11,884 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-04-19 | 2022-05-19 | 11,884 | — | $0 | 11,884 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-04-19 | 2022-03-15 | 11,884 | — | $0 | 11,884 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-04-19 | 2021-04-21 | 11,884 | — | $0 | 11,884 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-04-19 | 2026-09-01 | 2,971 | — | $0 | 3,143 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-03-16 | 2023-03-23 | 688 | — | $0 | 688 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-03-16 | 2022-11-18 | 688 | — | $0 | 688 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-03-16 | 2022-05-19 | 688 | — | $0 | 688 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-03-16 | 2022-03-15 | 688 | — | $0 | 688 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | P Buy deriv | 2021-03-16 | 2021-03-26 | 688 | — | $0 | 688 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | P Buy | 2021-03-16 | 2021-03-26 | 2,409 | $41.51 | $100.0K | 2,409 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2020-07-16 | 2026-09-01 | 172 | — | $0 | 172 | SEC↗ |
| ANCN Anchiano Therapeutics Ltd. | A Award deriv | 2020-07-16 | 2021-03-11 | 55,000 | — | $0 | 55,000 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2020-07-16 | 2026-09-01 | 172 | — | $0 | 172 | SEC↗ |